60% of Healthcare and Life Sciences Investors Plan to Increase M&A Activity in 2023 Despite Recession Concerns

Commentary by: Todd Perman, CCIM, Vice Chairman, Global Healthcare Services

The healthcare economic landscape has faced many obstacles in the past few years. Recession concerns continued inflation and increasing interest rates are several of the reasons healthcare investors have cautiously deployed capital as of late. 2023 looks to change that outlook, according to KPMG’s 2023 Healthcare and Life Sciences Investment Outlook. While certain economic factors will remain, 60% of the 300 healthcare executives surveyed expect to increase M&A activity this year. Strategic investment areas that are key to capital strategy for the year ahead include new offerings, operational efficiency and milestone-based deals.

As investors seek innovative deals to fill pipelines, it’s predicted we’ll see a variety of significant, highly strategic deals to occur in 2023.

To read the full article, click here.

All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our

Sign Up for Our Newsletter